Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Kazakhstan
Kazakhstan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.2% in 2024. ▬ Flat
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Kazakhstan, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Kazakhstan recorded 0.2% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the highest value across all 10 years on record.
Compared with earlier readings it is unchanged over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Kazakhstan peaked at 0.2% in 2015 and was at its lowest, 0.2%, in 2015.
Kazakhstan ranks 78th of 215 countries on this measure, in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Kazakhstan, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.2% | — |
| 2016 | 0.2% | +0.0% |
| 2017 | 0.2% | +0.0% |
| 2018 | 0.2% | +0.0% |
| 2019 | 0.2% | +0.0% |
| 2020 | 0.2% | +0.0% |
| 2021 | 0.2% | +0.0% |
| 2022 | 0.2% | +0.0% |
| 2023 | 0.2% | +0.0% |
| 2024 | 0.2% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.2% | 5 |
| 2020s | 0.2% | 0.2% | 0.2% | 5 |
Countries ranked near Kazakhstan
- 78 Anguilla 0.2% compare
- 78 Antigua and Barbuda 0.2% compare
- 78 Aruba 0.2% compare
- 78 Bahamas 0.2% compare
- 78 Barbados 0.2% compare
- 78 Bonaire, Sint Eustatius and Saba 0.2% compare
- 78 British Virgin Islands 0.2% compare
- 78 Cayman Islands 0.2% compare
- 78 Curaçao 0.2% compare
- 78 Dominica 0.2% compare
- 78 Fiji 0.2% compare
- 78 Grenada 0.2% compare
- 78 Guadeloupe 0.2% compare
- 78 India 0.2% compare
- 78 Jamaica 0.2% compare
- 78 Libya 0.2% compare
- 78 Maldives 0.2% compare
- 78 Martinique 0.2% compare
- 78 Montserrat 0.2% compare
- 78 Nepal 0.2% compare
- 78 North Macedonia 0.2% compare
- 78 Pakistan 0.2% compare
- 78 Puerto Rico 0.2% compare
- 78 Saint Barthélemy 0.2% compare
- 78 Saint Kitts and Nevis 0.2% compare
- 78 Saint Lucia 0.2% compare
- 78 Saint Martin (French part) 0.2% compare
- 78 Saint Vincent and the Grenadines 0.2% compare
- 78 Sint Maarten (Dutch part) 0.2% compare
- 78 Suriname 0.2% compare
- 78 Tajikistan 0.2% compare
- 78 Turks and Caicos Islands 0.2% compare
- 78 United States Virgin Islands 0.2% compare
More development goals data for Kazakhstan
- Red List Index 0.893 (2025)
- Number of refugees per 100,000 population, by country of origin 19.87 (2025)
- Manufacturing value added per capita 1,362 (2025)
- Number of transboundary breeds 48 (2025)
- Number of transboundary breeds (not extinct) 48 (2025)
- Number of transboundary breeds with unknown risk status 48 (2025)
- Number of local breeds with unknown risk status 75 (2025)
- Number of local breeds (not extinct) 75 (2025)
- Number of local breeds kept in the country 75 (2025)
- Infant deaths 3,006 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Kazakhstan?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Kazakhstan was 0.2% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Kazakhstan?
- The highest recorded value was 0.2% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Kazakhstan?
- The lowest recorded value was 0.2% in 2015.
- How does Kazakhstan rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Kazakhstan ranks 78th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Kazakhstan?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Kazakhstan data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).